Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice
| Image |  |
|---|---|
| Description | scientific article published on 08 April 2014 |
| Author/s | |
| Publication date | April 8, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |